FibriCheck

CE-, FDA- & TGA-approved medical app

FibriCheck is a global digital cardiovascular health company focused on early detection and management of atrial fibrillation (AF). Its regulatory-cleared, software-as-a-medical-device turns smartphones and wearables into medical-grade rhythm monitoring tools using clinically validated PPG technology. The platform supports prevention, diagnosis, and long-term management, with over 1.5 million users, 30 million recordings, and regulatory approvals across Europe, the UK, Switzerland, Australia, Singapore, and the U.S.